We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of NKGNW yet.

NKGNW Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2025, worth a combined $0 — down 100% from $14.1K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NKGNW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Rivernorth Capital Management, exiting entirely with an estimated $13.1K sold.

  • 0 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2025, down from 3 in Q1 2025.
  • Funds reported $0 of NKGen Biotech, Inc. Warrants stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2025 and 3 closed out, a net change of -3 holders.
  • The largest NKGen Biotech, Inc. Warrants seller in Q2 2025 was Rivernorth Capital Management, an estimated $13.1K sold.

Based on aggregated 13F filings for Q2 2025.